Center for Healthy Aging, Self-Management and Complex Care, Ohio State University, College of Nursing, Columbus, OH, United States of America.
Department of Cancer Control Survivorship, Ohio State University Comprehensive Cancer Center, Columbus, OH, United States of America.
PLoS One. 2023 May 19;18(5):e0286058. doi: 10.1371/journal.pone.0286058. eCollection 2023.
Colorectal cancer (CRC) survivors often experience long-term symptoms after cancer treatments. But gastrointestinal (GI) symptom experiences are under-investigated in CRC survivors. We described persistent GI symptoms after cancer treatments in female CRC survivors and assessed GI symptoms' risk and life-impact factors.
A cross-sectional study utilized data from the Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) study that recruited postmenopausal women. Correlation analyses and multivariable linear regression models were used.
CRC survivors after cancer treatments were included (N = 413, mean age 71.2 years old, mean time since diagnosis = 8.1 years). 81% of CRC survivors experienced persistent GI symptoms. Bloating/gas was the most prevalent (54.2%± 0.88) and severe GI symptom, followed by constipation (44.1%±1.06), diarrhea (33.4%±0.76), and abdominal/pelvic pain (28.6%±0.62). Significant risk factors for GI symptoms include time since cancer diagnosis (<5 years), advanced cancer stage, high psychological distress, poor dietary habits, and low physical activity. Fatigue and sleep disturbance were the most significant risk factors for long-term GI symptoms (β = 0.21, t = 3.557; β = 0.20, t = 3.336, respectively, Ps < .001). High severity of GI symptoms was positively associated with poor quality of life (QOL), increased daily life interferences (social and physical functions), and low body image satisfaction (Ps < .001).
Women CRC survivors experience a high GI symptom burden, highlighting the need to inform policy and improve the QOL of cancer survivors. Our findings will aid in identifying those more vulnerable to symptoms, and inform future survivorship care interventions (i.e., community-based cancer symptom management) by considering multiple risk factors (e.g., psychological distress).
结直肠癌(CRC)幸存者在癌症治疗后常长期出现症状。但 CRC 幸存者的胃肠道(GI)症状体验研究不足。我们描述了癌症治疗后女性 CRC 幸存者持续存在的 GI 症状,并评估了 GI 症状的风险和生活影响因素。
一项横断面研究利用了女性健康倡议(WHI)癌症后生命和长寿(LILAC)研究的数据,该研究招募了绝经后女性。使用了相关分析和多变量线性回归模型。
纳入了癌症治疗后的 CRC 幸存者(N = 413,平均年龄 71.2 岁,诊断后时间平均为 8.1 年)。81%的 CRC 幸存者经历了持续的 GI 症状。腹胀/气是最常见的(54.2%±0.88)和严重的 GI 症状,其次是便秘(44.1%±1.06)、腹泻(33.4%±0.76)和腹部/骨盆疼痛(28.6%±0.62)。GI 症状的显著风险因素包括癌症诊断后时间(<5 年)、晚期癌症分期、较高的心理困扰、不良的饮食习惯和较低的身体活动水平。疲劳和睡眠障碍是长期 GI 症状的最重要的风险因素(β=0.21,t=3.557;β=0.20,t=3.336,均 P<0.001)。高严重程度的 GI 症状与较差的生活质量(QOL)、日常生活干扰增加(社会和身体功能)和身体形象满意度降低有关(P<0.001)。
女性 CRC 幸存者经历了高的 GI 症状负担,这突出表明需要告知政策并改善癌症幸存者的生活质量。我们的研究结果将有助于确定那些更容易出现症状的人,并通过考虑多种风险因素(如心理困扰),为未来的生存者护理干预(如社区癌症症状管理)提供信息。